Osteo-articular manifestations of amyloidosis

Best Practice and Research: Clinical Rheumatology

Volumn 26, Issue 4, 2012, Pages 459-475

  M'Bappé, Pauline ^a   Grateau, Gilles ^a  

^a HÔPITAL TENON   (France)

Author keywords

AL amyloidosis; Amyloidosis; Carpal tunnel syndrome; Pseudo rheumatoid arthritis; Transthyretin amyloidosis; 2 Microglobulin

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID P COMPONENT; AMYLOID PROTEIN; APOLIPOPROTEIN A1; BETA 2 MICROGLOBULIN; BORTEZOMIB; C REACTIVE PROTEIN; COLCHICINE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; GADOLINIUM; GLYCOSAMINOGLYCAN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; LENALIDOMIDE; MELPHALAN; NONSTEROID ANTIINFLAMMATORY AGENT; POMALIDOMIDE; PREALBUMIN; PREDNISONE; TECHNETIUM 99M; THALIDOMIDE;

AGING; ALZHEIMER DISEASE; AMYLOIDOSIS; ANKYLOSING SPONDYLITIS; ARTHRALGIA; ARTHROPATHY; ARTHROSCOPY; ARTICLE; BONE DESTRUCTION; BONE SCINTISCANNING; BONE SWELLING; BONE TUMOR; CARPAL TUNNEL SYNDROME; CERVICAL SPINE; CHONDROSARCOMA; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; DRUG MEGADOSE; ELECTROMYOGRAM; ELECTRON MICROSCOPY; EXTRACELLULAR MATRIX; FAMILIAL AMYLOIDOSIS; FIBER; HAND OSTEOARTHRITIS; HEART FAILURE; HEMODIALYSIS PATIENT; HISTOPATHOLOGY; HUMAN; INCIDENCE; KIDNEY AMYLOIDOSIS; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; MUSCLE ATROPHY; MYELOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS; OSTEOSCLEROSIS; PATHOLOGIC FRACTURE; PERIPHERAL NEUROPATHY; POLYARTHRITIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEOMICS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; SPINE FRACTURE; SPONDYLOARTHROPATHY; SYNOVECTOMY; SYNOVIAL FLUID; TEMPORAL ARTERITIS;

EID: 84867389058     PISSN: 15216942     EISSN: 15321770     Source Type: Journal    
DOI: 10.1016/j.berh.2012.07.003     Document Type: Review

References (89)

1. J.D. Sipe, M.D. Benson, and J.N. Buxbaum Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis Amyloid 17 2010 101 110
2. S. Sethi, J.A. Vrana, and J.D. Theis Laser microdissection and mass spectrometry-based proteomics aids the diagnosis and typing of renal amyloidosis Kidney International April 11 2012 [Epub ahead of print]
3. M.B. Pepys, D.R. Booth, and W.L. Hutchinson Amyloid P component. A critical review Amyloid 4 1997 274 295
4. J.D. Sipe, and A.S. Cohen Review: history of the amyloid fibril Journal of Structural Biology 130 2000 88 98
5. T.B. Drüeke, and Z.A. Massy Beta2-microglobulin Seminars in Dialysis 22 2009 378 380
6. N. Magy-Bertrand Les amyloses à transthyrétine La Revue de Médecine Interne 28 2007 306 313
7. G. Merlini, and V. Bellotti Molecular mechanisms of amyloidosis New England Journal of Medicine 349 2003 583 596
8. G. Grateau, J. Verine, and M. Delpech Les amyloses, un modèle de maladie du repliement des protéïnes Médecine Sciences (Paris) 21 2005 627 633
9. R.A. Kyle, A. Linos, and C.M. Beard Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989 Blood 79 1992 1817 1822
10. R.W. Simms, M.N. Prout, and A.S. Cohen The epidemiology of AL and AA amyloidosis G. Husby, Reactive amyloidosis and the acute phase response. Baillière's clinical rheumatology 1994 Baillière Tindall London 627 634
11. M.A. Gertz, F.K. Buadi, and S.R. Hayman Immunoglobulin D amyloidosis: a distinct entity Blood 119 2012 44 48
12. M.A. Gertz Immunoglobulin light chain amyloidosis: 2011 update on diagnosis, risk-stratification, and management American Journal of Hematology 86 2011 180 186
13. B. Terrier, A. Jaccard, and J.L. Harousseau The clinical spectrum of IgM-related amyloidosis: a French nationwide retrospective study of 72 patients Medicine (Baltimore) 87 2008 99 109
14. R.A. Kyle, and P.R. Geipp Amyloidosis (AL). Clinical and laboratoty features in 229 cases Mayo Clinic Proceedings 58 1983 665 683
15. J. Villaumey, B. Larget-Pied, and P. Pointud Articular complications of Kahler's disease. Results of a survey of 1953 cases of plasmocytic myelomas Revue du Rhumatisme et des Maladies Osteo-articulaires 42 1975 25 34
16. B. Fautrel, J.P. Fermand, and J. Sibilia Amyloid arthropathy in the course of multiple myeloma Journal of Rheumatology 29 2002 1473 1481
17. E. Krause, A. Argiles, and R. Bataille Amylose synoviale révélatrice de myélome. Aspects cliniques, arthroscopiques et immunochimiques Revue du Rhumatisme et des Maladies Osteo-articulaires 55 1988 689 692
18. M.A. Gertz, and R.A. Kyle Primary systemic amyloidosis - a diagnostic primer Mayo Clinic Proceedings 64 1989 1505 1519
19. P. Blanco, J.F. Viallard, and B. Bonotto Les atteintes articulaires de l'amylose AL Annales de médecine interne 150 1999 287 293
20. S. Hamza, F. Landolsi, and H. Sahli Light chain multiple myeloma revealed by an amyloid arthropathy. A report of two cases La Revue de Médecine Interne 25 2004 390 394
21. R.H. Falk, R.L. Comenzo, and M. Skinner The systemic amyloidoses New England Journal of Medicine 337 1997 898 909
22. E. Hachulla, M. Deveaux, and B. Duquesnoy Cartographie de l'amylose par scintigraphie au composant sérique amyloïde P marqué à l'iode 123: mythe ou réalité? La Revue de Médecine Interne 15 1994 238 239
23. P. Rodon, P. Friocourt, and S. Blanchet Temporal artery involvement revealing AL amyloidosis and Ig D monoclonal gammapathy Journal of Rheumatology 23 1996 189 190
24. P. Lafforgue, E. Senbel, and D. Figarella-Granger Systemic amyloidosis AL with temporal artery involvement revealing lymphoplasmatic malignancy in a man presenting as polymyalgia rheumatica Ann Rheum Dis 52 1993 158 160
25. D. Resnick, and G. Niwayama Amyloidosis Diagnosis of bone and joint disorders 2nd ed. 1988 WB Saunders Philadelphia 2387 2395
26. T. Prokaeva, B. Spencer, and M. Kaut Soft tissue, joint, and bone manifestations of AL amyloidosis Arthritis & Rheumatism 56 2007 3858 3868
27. G.A. Katz, J.B. Peter, and C.M. Pearson The shoulder - pad sign- a diagnostic feature of amyloid arthropathy New England Journal of Medicine 288 1973 354 355
28. R.M. Flipo, X. Deprez, and P. Fardellone Polyarthrite rhumatoïde et myélome multiple: a propos de vingt-deux observations, Résultats d'une enquête nationale multicentrique Revue du Rhumatisme 60 1993 269 273
29. D.A. Gordon, W. Pruzanski, M.A. Ogryzlo, and H.A. Little Amyloid arthritis simulating rheumatoid disease in five patients with multiple myeloma American Journal of Medicine 55 1973 142 154
30. S. Lakhanpal, Li Cy, and M.A. Gertz Synovial fluid analysis for diagnosis of amyloid arthropathy Arthritis & Rheumatism 30 1987 419 423
31. C. Faure, B. Venin, and J.C. Bousquet Amylose osseuse primitive: aspects en IRM Radiologie 76 1995 1025 1027
32. J.C. Evans, M. Murphy, and B. Eyes Extensive soft tissue uptake of 99Tcm methylene diphosphonate in a patient with multiple myeloma British Journal of Radiology 73 2000 1018 1020
33. A. Mekinian, E. Ghrenassia, and G. Pop Visualisation of amyloid arthropathy in light-chain systemic amyloidosis on F-18 FDG PET/CT Scan Clinical Nuclear Medicine 36 2011 52 53
34. B.J. Penrod, and C.S. Resnick Amyloid arthropathy Arthritis & Rheumatism 40 1997 1903 1905
35. A.D. Cohen, and R.L. Comenzo Systemic light-chain amyloidosis: advances in diagnosis, prognosis, and therapy Hematology American Society of Hematology Education Program 2010 2010 287 294
36. G. Palladini, and G. Merlini Transplantation vs. conventional-dose therapy for amyloidosis Current Opinion in Oncology 23 2011 214 220
37. A. Dispenzieri, M.Q. Lacy, and J.A. Katzmann Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem transplantation Blood 107 2006 3378 3383
38. Van Gameren II, M.H. van Rijswijk, and J. Bijzet Histological regression of amyloid in AL amyloidosis is exclusively seen after normalization of serum free light chain Haematologica 94 2009 1094 1100
39. J. Shi, J. Guan, and B. Jiang Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway Proceedings of Natural Academy of Sciences USA 107 2010 4188 4193
40. G. Palladini, A. Barassi, and C. Klersy The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis Blood 116 2010 3426 3430
41. G. Palladini, C. Campana, and C. Klersy Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis Circulation 107 2003 2440 2445
42. M.A. Gertz, and G. Merlini Definition of organ involvement and response to treatment in AL amyloidosis: an updated consensus opinion [12th international symposium on amyloidosis abstracts] Amyloid 17 2010 48 49
43. G. Merlini, D.C. Seldin, and M.A. Gertz Amyloidosis: pathogenesis and new therapeutic options Journal of Clinical Oncology 29 2011 1924 1933
44. Kyle Ra, M.A. Gertz, and P.R. Greipp A trial of three regimens for primary amiloidosis: colchicine alone, melphalan and prednisone, prednisone and colchicine New England Journal of Medicine 336 1997 1202 1207
45. M. Skinner, V. Sanchorawala, and D.C. Seldin High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study Annals of Internal Medicine 140 2004 85 93
46. M.T. Cibeira, V. Sanchorawala, and D.C. Seldin Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients Blood 118 2011 4346 4352
47. G. Palladini, V. Perfetti, and L. Obici Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation Blood 103 2004 2936 2938
48. A. Jaccard, P. Moreau, and V. Leblond High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis New England Journal of Medicine 357 2007 1083 1093
49. S.W. Dubrey, D.E. Reece, and V. Sanchorawala Bortezomib in a phase 1 trial for patients with relapsed AL amyloidosis: cardiac responses and overall effects QJM 104 2011 957 970
50. G. Palladini, P. Russo, and A. Foli Salvage therapy with lenalidomide and dexamethasone in patients with advanced AL amyloidosis refractory to melphalan, bortezomib, and thalidomide Annals of Hematology 91 2012 89 92
51. G. Bollée, B. Guery, and D. Joly Presentation and outcome of patients with systemic amyloidosis undergoing dialysis Clinical Journal of the American Society of Nephrology 3 2008 375 381
52. B.R. Dey, S.S. Chung, and T.R. Spitzer Cardiac transplantation followed by dose-intensive melphalan and autologous stem-cell transplantation for light chain amyloidosis and heart failure Transplantation 2010 905 911
53. S.M. Herrmann, M.A. Gertz, and M.D. Stegall Long-term outcomes of patients with light chain amyloidosis (AL) after renal transplantation with or without stem cell transplantation Nephrology Dialysis Transplantation 26 2011 2032 2036
54. M.A. Gertz, and R.A. Kyle Myopathy in primary systemic amyloidosis Journal of Neurology, Neurosurgery & Psychiatry 60 1996 655 660
55. J.P. Metzler, J.L. Fleckenstein, and C.L. White MRI evaluation of amyloid myopathy Skeletal Radiology 21 1992 463 465
56. M.A. Gertz, R.A. Kyle, W.L. Griffing, and G.G. Hunder Jaw claudication in primary systemic amyloidosis Medicine (Baltimore) 65 1986 173 179
57. J.K. Rao, and N.B. Allen Primary systemic amyloidosis masquerading as giant cell arteritis. Case report and review of the literature Arthritis & Rheumatism 36 1993 422 425
58. R.A. Kyle, and E.D. Baird Amyloidosis: review of 236 cases Medicine (Baltimore) 54 1975 271 299
59. R.A. Kyle, and M.A. Gertz Primary systemic amyloidosis: clinical and laboratory features in 474 cases Seminars in Hematology 32 1995 45 59
60. S.E. Pambuccian, I.D. Horyd, and T. Calute Amyloidoma of bone plasma cell/plasmacytoid neoplasm. Report of three cases and review of the literature The American Journal of Surgical Pathology 21 1997 179 186
61. H. Ajlani, K. Zaouia, and A. Chtourou Amylose primitive et étagée du rachis dorsolombaire compliquée d'une parapléie Rev chir réparat l'appareil locomoteur 94 2008 498 502
62. F. Porchet, V.K.H. Sonntag, and N. Vrodos Case report and review of the literature: Cervical Amyloidoma of C2 Spine 23 1998 133 138
63. A. Saito, and F. Gejyo Current clinical aspects of dialysis-related amyloidosis in chronic dialysis patients Therapeutic Apheresis and Dialysis 10 2006 316 320
64. L.M. Dember, and B.L. Jaber Dialysis-related amyloidosis: late finding or hidden epidemic? Seminars in Dialysis 19 2006 105 109
65. C. Mrowka, and H. Schiffl Comparative evaluation of beta2-microglobulin removal by different hemodialysis membranes: a six year follow-up Nephron 63 1993 368 369
66. R. Furuya, H. Kumagai, and M. Takahashi Ultrapure dialysate reduces plasma levels of beta2-microglobulin and pentosidine in hemodialysis patients Blood Purification 23 2005 311 316
67. A. Gaucher, M. Kessler, and P. Netter Complications ostéo- articulaires des hémodialysés Encycl Med Chir 1997 (Elsevier Paris) Appareil Locomoteur 14-276-A-10, 5 pp.
68. T. Bardin, and D. Kuntz Nouvelles manifestations articulaires chez l'hémodialysé. L'actualité rhumatologique 1986 Expansion scientifique française Paris 314-322
69. J. Zingraff, and T. Druëke Amylose à la Bêta 2-microglobuline. In les amyloses G. Grateau, M.D. Benson, M. Delpech, Flammarion 1995 429 443
70. D. Kuntz, B. Naveau, and T. Bardin Destructive spondylarthropathy in hemodialyzed patients: a new syndrome Arthritis & Rheumatism 7 1984 369 375
71. J.L. Sebert, P. Fardellone, and H. Deramond Spondylarthropathie destructrice avec depôts amyloïdes chez 3 patients en hémodialyse chronique Revue du rhumatisme et des maladies ostéo-articulaires 53 1986 459 465
72. N. Magy, J.J. Liepnieks, and H. Gil A transthyretin mutation (Tyr78Phe) associated with peripheral neuropathy, carpal tunnel syndrome and skin amyloidosis Amyloid 10 2003 29 33
73. V. Planté-Bordeneuve, A. Ferreira, and T. Lalu Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP) Neurology 69 2007 693 698
74. L. Lobato, I. Beirao, and M. Silva End-stage renal disease and dialysis in hereditary amyloidosis TTR V30M: presentation, survival and prognostic factors Amyloid 11 2004 27 37
75. M. Brett, M.R. Persey, and M.M. Reilly Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosis Brain 122 1999 183 190
76. M.A. Gertz, R.A. Kyle, and S.N. Thibodeau Familial amyloidosis: a study of 52 north-american-born patients examined during a 30-year period Mayo Clinic Proceedings 67 1992 428 440
77. M. Kitajima, Y. Korogi, and M. Yamura Familial amyloid polyneuropathy: hypertrophy of ligaments supporting the spinal cord American Journal of Neuroradiology 25 2004 1599 1602
78. N. Harats, R. Worth, and M.D. Benson Spinal claudication in systemic amyloidosis Journal of Rheumatology 16 1989 1003 1006
79. V. Planté-Bordeneuve, and G. Said Familial amyloid polyneuropathy Lancet Neurology 10 2011 1086 1097
80. G.G. Cornwell Jr., K.H. Johnson, and P. Westermark The age related amyloids: a growing family of unique biochemical substances Journal of Clinical Pathology 48 1995 984 989
81. N. Magy-Bertrand, J.L. Dupond, and F. Mauny Incidence of amyloidosis over 3 years: the AMYPRO study Clinical and Experimental Rheumatology 26 2008 1074 1078
82. M. Tanskanen, T. Peuralinna, and T. Polvikoski Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study Annals of Internal Medicine 40 2008 232 239
83. M. Ueda, Y. Horibata, and M. Shono Clinicopathological features of senile systemic amyloidosis: an ante- and post-mortem study Modern Pathology 24 2011 1533 1544
84. Takey Yi, T. Hattori, and T. Gono Senile systemic amyloidosis presenting as bilateral carpal tunnel syndrome Amyloid 9 2002 252 255
85. B. Ng, L.H. Connors, and R. Davidoff Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis Archives of Internal Medicine 165 2005 1425 1429
86. T. Sueyoshi, M. Ueda, and H. Jono Wild-type transthyretin-derived amyloidosis in various ligaments and tendons Human Pathology 42 2011 1259 1264
87. T. Sueyoshi, M. Ueda, and A. Sei Spinal multifocal amyloidosis derived from wild-type transthyretin Amyloid 18 2011 165 168
88. A. Wullbrand, W. Saeger, and H.P. Missmahl Amyloid in intervertebral discs of surgery and autopsy material. A new class of amyloid? Virchows Archiv A 416 1990 335 341
89. S. Solomon, C.L. Murphy, and D. Kestler Amyloid contained in the knee joint meniscus is formed from Apolipoprotein A-I Arthritis & Rheumatism 11 2006 3545 3550